Dr. Iacoboni Highlights Key Lymphoma Abstracts Presented This Year

By Raj Chakraborty, MD, Ashwin Kishtagari, MD, Ayalew Tefferi, MD, Edward Cliff, MD - Last Updated: July 30, 2024

In this episode of the “Blood Cancer Talks” podcast, hosts Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD, spoke with Gloria Iacoboni, MD, PhD, a hematologist at the University Hospital Vall d’Hebron in Barcelona, Spain, to highlight key lymphoma abstracts from the 2024 American Society of Clinical Oncology Annual Meeting and European Hematology Association 2024 Hybrid Congress.

The papers referenced on the episode reported findings from the EPCORE NHL-5, TRANSFORM, ECHO RCT, HD21, and EPCORE CLL-1 studies, as well as a study on pirtobrutinib, venetoclax, and obinutuzumab in chronic lymphocytic leukemia.

Dr. Schmidt on Quadruplet Therapy for Newly Diagnosed, Transplant Ineligible MM

Discussing Lower-Risk MDS Treatment Options With Dr. Stahl

Dr. Gerds on the Treatment of Polycythemia Vera

MRD Use in Multiple Myeloma: Clinical Practice, Clinical Trials, and Drug Approval

Dr. Tefferi on Recent Ruxolitinib Combination Trials for Myelofibrosis

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

Dr. Iacoboni Highlights Key Lymphoma Abstracts Presented This Year

Related